A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Radiation Research"
DOI: 10.1093/jrr/rrac069
Abstract: Abstract This study assessed the efficacy of chemoradiotherapy for squamous cell carcinoma of the anal canal (SCCAC). Patients with T1–4N0-3M0 SCCAC received chemoradiotherapy with 5-fluorouracil (5-FU, 800 mg/m2/day, 96-h infusion) and mitomycin-C (MMC, 10 mg/m2… read more here.
Keywords: cell carcinoma; year; anal canal; squamous cell ... See more keywords